Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Crockett Nigel Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 442 shares @ $20, valued at $8.8k
10/03/2023 144 Form 144 - Report of proposed sale of securities:
07/06/2023 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 451 shares @ $25.1, valued at $11.3k
07/03/2023 144 Form 144 - Report of proposed sale of securities:
04/05/2023 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Sold 447 shares @ $21.11, valued at $9.4k
01/05/2023 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 17,500 shares @ $0
Sold 1,801 shares @ $29.06, valued at $52.3k
Granted 35,000 options to buy @ $29.6, valued at $1M
01/05/2022 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 15,000 shares @ $0
Granted 30,000 options to buy @ $60.87, valued at $1.8M
07/14/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/25/2020 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 44,757 options to buy @ $15.36, valued at $687.5k
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/06/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/30/2019 4 Crockett Nigel (Chief Business Officer) has filed a Form 4 on BICYCLE THERAPEUTICS plc
Txns: Granted 152,174 options to buy @ $11.66, valued at $1.8M
09/30/2019 3 Crockett Nigel (Chief Business Officer) has filed a Form 3 on BICYCLE THERAPEUTICS plc

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy